Codi QR

Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study

<p>Abstract</p> <p>Background</p> <p>Erlotinib and pemetrexed have been approved for the second-line treatment of non-small cell lung cancer (NSCLC). These two agents have different mechanisms of action. Combined treatment with erlotinib and pemetrexed could potentially augment the antitumor activit...

Descripció completa

Guardat en:
Autors principals: Minami Seigo, Kijima Takashi, Takahashi Ryo, Kida Hiroshi, Nakatani Takeshi, Hamaguchi Masanari, Takeuchi Yoshiko, Nagatomo Izumi, Yamamoto Suguru, Tachibana Isao, Komuta Kiyoshi, Kawase Ichiro
Format: Artigo
Idioma:Inglês
Publicat: BMC 2012-07-01
Col·lecció:BMC Cancer
Matèries:
Combination
Erlotinib
Pemetrexed
NSCLC
Phase I
Accés en línia:http://www.biomedcentral.com/1471-2407/12/296
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars